- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- News News
- Join Join
Policy Recommendations Vermont
2019-2020 Improvements and Recommendations for Vermont
Vermont state lawmakers spent time in the 2019 legislative session considering legislation to regulate and tax cannabis in the Green Mountain State, however, that legislation was tabled for action in 2020. Prior to turning to COVID emergency measures, state legislators were advancing bills (S 54) that would regulate and tax cannabis and provide for criminal record expungement of cannabis possession convictions (S 294). These measures are expected to receive new consideration in the 2021 legislative session.
Vermont also expanded some features of its medical program as part of the state's response to COVID. These enhancements included maintaining operations of medical cannabis businesses, and authorization of curbside pickup and delivery to reduce patient exposure to close contact. Vermont also extended expiring patient identification cards for 90 days, allowing patients to maintain safe access without having to visit a doctor to determine ongoing eligibility. ASA recommends permanently maintaining these new program features.
In addition to these recommendations ASA also encourages state lawmakers to address serious flaws with the state medical program that is on the brink of collapse. Lack of legal medical cannabis product supplies, poor medical product quality and diversity and a limited population of licensed medical cannabis retailers has created an environment in which patients cannot secure access to safe, legal, third-party laboratory tested medical cannabis. As a result patients are abandoning the state's medical program in favor of seeking access in neighboring states with more advanced medical systems. ASA asks that state lawmakers and regulators spend time in 2021 fixing these issues that are critical to ensuring patient safety, as well as remove requirements that patients may only access a single legal medical retailer.